Cargando…
Regulation of PPARα by APP in Alzheimer disease affects the pharmacological modulation of synaptic activity
Among genetic susceptibility loci associated with late-onset Alzheimer disease (LOAD), genetic polymorphisms identified in genes encoding lipid carriers led to the hypothesis that a disruption of lipid metabolism could promote disease progression. We previously reported that amyloid precursor protei...
Autores principales: | Sáez-Orellana, Francisco, Leroy, Thomas, Ribeiro, Floriane, Kreis, Anna, Leroy, Karelle, Lalloyer, Fanny, Baugé, Eric, Staels, Bart, Duyckaerts, Charles, Brion, Jean-Pierre, Gailly, Philippe, Octave, Jean-Noël, Pierrot, Nathalie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410016/ https://www.ncbi.nlm.nih.gov/pubmed/34228639 http://dx.doi.org/10.1172/jci.insight.150099 |
Ejemplares similares
-
Sex-regulated gene dosage effect of PPARα on synaptic plasticity
por: Pierrot, Nathalie, et al.
Publicado: (2019) -
Alzheimer’s Disease, a Lipid Story: Involvement of Peroxisome Proliferator-Activated Receptor α
por: Sáez-Orellana, Francisco, et al.
Publicado: (2020) -
Conditional deletion of KCC2 impairs synaptic plasticity and both spatial and nonspatial memory
por: Kreis, Anna, et al.
Publicado: (2023) -
Cortical cells reveal APP as a new player in the regulation of GABAergic neurotransmission
por: Doshina, Anna, et al.
Publicado: (2017) -
Amyloid Precursor Protein (APP) Controls the Expression of the Transcriptional Activator Neuronal PAS Domain Protein 4 (NPAS4) and Synaptic GABA Release
por: Opsomer, Rémi, et al.
Publicado: (2020)